28-Oct-2024
Download PDF
Ajanta Pharma
We hereby inform that the Board at the Board meeting held on Monday 28th October 2024 has inter-alia approved the Unaudited (Consolidated & Standalone) Financial Results of the Company for the quarter and half year ended 30.09.2024 and declared 1st interim dividend for FY 2025.PFA enclosed outcome of Board Meeting for more details.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
